comprehensive -WSS

comprehensive

author：entertainment 2025-10-01 21:23:52 - browse：8516

Rep. Larry Bucshon (R-Ind.) received a significant amount of campaign donations from the pharmaceutical industry in the second quarter of 2023. House Television via AP

WASHINGTON — The pharmaceutical industry has been flooding the campaign coffers of Rep. Larry Bucshon, a cardiothoracic surgeon and Republican from Indiana, according to a STAT analysis of this quarter’s filings.

CEOs of pharmaceutical giants, executives of the brand-drug lobby PhRMA, and companies’ political action committees all gave in higher-than-usual numbers to the rank-and-file House member last quarter. The total was nearly $56,000 between April 14 and June 30.

Bucshon is a member of the House Energy & Commerce Committee, which works on drug pricing issues, and the GOP Doctors Caucus, but he doesn’t hold leadership positions in either.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Medicare details structure of new drug price negotiation program
Next article： Can medical device makers keep up in the race to treat obesity?

leisure time

focus

WSS

Bispecific antibodies are next new thing in cancer immunotherapy

Pioneering cancer drug will cost $475,000. Analysts call it a bargain

Pioneering cancer drug will cost $475,000. Analysts call it a bargain

How a symptom of dementia informs our understanding of creativity

How a symptom of dementia informs our understanding of creativity

Unicorn down: Following layoffs, Biofourmis CEO quietly departs

focus

comprehensive

focus

Guidelines to prevent youth baseball injuries need more muscle

FDA panel gives mixed vote on blood pressure devices

Hollywood unions extend contract negotiations for actors

Canadian wildfire dangers should prompt more proactive mitigation from government: Experts

Cancer drug shortages should be causing more outrage

Senate panel passes drug pricing bills, but drops one PBM reform

The high cost of giving birth even with insurance

Pioneering cancer drug will cost $475,000. Analysts call it a bargain

Duchenne breakthrough therapy leaves behind pioneering families

Feds fine Medicare Advantage plans for overcharging members

focus

Apellis safety probe of eye disease drug centers on injection needle

A public health expert passes on football's full body collisions for youths

Diversity in medical illustrations gets boost from Chidiebere Ibe

How a symptom of dementia informs our understanding of creativity

Bispecific antibodies are next new thing in cancer immunotherapy

What AAP's gender

Wikipedia

leisure time

focus

knowledge